Kura Sushi USA (NASDAQ:KRUS) Stock, Quote.Headers.trade-ideas

Kura Sushi USA

Kura Sushi USA Inc is a Japanese restaurant company. It operates revolving sushi chain restaurants in the United States. It provides access to the revolving and express conveyor belts, on-demand ordering screen, plate slot, and the Bikkura-Pon rewards machine. The company offers several dishes, including Dashi Olive Salmon, Tomago, Sweet Shrimp, Tuna, Garlic Tuna Steak, Salmon, among others. Geographically, it derives revenue from the United States of America.

consumers ai2

Long Ideas

News

Pre-Market Outlook

Markets

Trading Ideas

CONN

HELE

KRUS

Top 5 Consumer Stocks That May Explode In Q3

Penny,Stock,Investments,Taking,Off,Concept

Intraday Update

Movers

AEHL

AEHR

ALAR

ANVS

CETU

DLPN

FENG

FUFU

GATO

IDYA

IONM

KZIA

LGMK

LGVN

LNTH

LUCY

NAAS

NISN

QURE

RMCF

RXST

SDST

SEEL

SISI

SNGX

TCJH

TMDX

VRPX

VSEE

VVPR

ZAPP

Why SeaStar Medical Holding Shares Are Trading Lower By Around 34%? Here Are Other Stocks Moving In Wednesday&#39;s Mid-Day Session

movers image

Kura Sushi Posts Weak Q3 Results, Joins LegalZoom.com And Other Big Stocks Moving Lower In Wednesday&#39;s Pre-Market Session

Kura Sushi USA, Inc. - Class A Common Stock

Kura Sushi USA Inc

WIIM

BNED

SNBR

Shares of retail companies are trading lower amid a possible selloff as the market pulls back from recent strength earlier this week.

US Secret Service Internal Investigation Reveals Communication Gaps And Lack Of Diligence Before July 13 Trump Shooting; Acting Director Calls For 'Paradigm Shift' And Acknowledges Failure To Provide Clear Guidance To Local Law Enforcement

Macro Notification

Econ #s

General

US Oil Rig Count Unchanged At 488, Down 19 YoY; NatGas Rigs Down 1 To 96; Gulf Of Mexico Rigs Down 1, Texas Up 2, Permian Up 1

<p>Deep-pocketed investors have adopted a bearish approach towards ARM Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARM#NASDAQ">ARM</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in ARM usually suggests something big is about to happen.</p>
<p>We gleaned this information from our observations today when Benzinga's options scanner highlighted 18 extraordinary options activities for ARM Holdings. This level of activity is out of the ordinary.</p>
<p>The general mood among these heavyweight investors is divided, with 22% leaning bullish and 77% bearish. Among these notable options, 7 are puts, totaling $290,559, and 11 are calls, amounting to $390,679.</p>
<h3>Expected Price Movements</h3>
<p>Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $110.0 to $270.0 for ARM Holdings during the past quarter. </p>
<h3>Analyzing Volume &amp; Open Interest</h3>
<p>Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in ARM Holdings's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to ARM Holdings's substantial trades, within a strike price spectrum from $110.0 to $270.0 over the preceding 30 days.</p>
<h3>ARM Holdings Call and Put Volume: 30-Day Overview</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1726851814_0.png" alt="Options Call Chart" /></p>
<h3>Biggest Options Spotted:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th style="text-align: right;"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>ARM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$16.05</td>
<td>$15.9</td>
<td>$16.05</td>
<td>$270.00</td>
<td>$80.2K</td>
<td>228</td>
<td style="text-align: right;">130</td>
</tr>
<tr>
<td>ARM</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>11/01/24</td>
<td>$35.75</td>
<td>$33.25</td>
<td>$33.67</td>
<td>$170.00</td>
<td>$77.6K</td>
<td>0</td>
<td style="text-align: right;">23</td>
</tr>
<tr>
<td>ARM</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>12/20/24</td>
<td>$10.85</td>
<td>$10.7</td>
<td>$10.85</td>
<td>$125.00</td>
<td>$54.2K</td>
<td>1.3K</td>
<td style="text-align: right;">242</td>
</tr>
<tr>
<td>ARM</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>09/20/24</td>
<td>$22.95</td>
<td>$20.8</td>
<td>$22.0</td>
<td>$160.00</td>
<td>$50.6K</td>
<td>26</td>
<td style="text-align: right;">23</td>
</tr>
<tr>
<td>ARM</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$16.6</td>
<td>$16.4</td>
<td>$16.4</td>
<td>$270.00</td>
<td>$39.3K</td>
<td>228</td>
<td style="text-align: right;">25</td>
</tr>
</tbody>
</table>
</p>
<h3>About ARM Holdings</h3>
<p>Arm Holdings is the IP owner and developer of the ARM architecture (ARM stands for Acorn RISC Machine), which is used in 99% of the world's smartphone CPU cores, and it also has high market share in other battery-powered devices like wearables, tablets, or sensors. Arm licenses its architecture for a fee, offering different types of licenses depending on the flexibility the customer needs. Customers like Apple or Qualcomm buy architectural licenses, which allows them to modify the architecture and add or delete instructions to tailor the chips to their specific needs. Other clients directly buy off-the-shelf designs from Arm. Off-the-shelf and architectural customers pay a royalty fee per chip shipped.</p>
<p>After a thorough review of the options trading surrounding ARM Holdings, we move to examine the company in more detail. This includes an assessment of its current market status and performance.</p>
<h3>Where Is ARM Holdings Standing Right Now?</h3>
<ul>
<li>With a volume of 2,690,796, the price of ARM is down -1.12% at $139.01. </li>
<li>RSI indicators hint that the underlying stock may be approaching overbought.</li>
<li>Next earnings are expected to be released in 56 days.</li>
</ul>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.</p>
<p>Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest ARM Holdings options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.</p>


Options

What the Options Market Tells Us About ARM Holdings

<p>Deep-pocketed investors have adopted a bullish approach towards Block (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SQ#NYSE">SQ</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in SQ usually suggests something big is about to happen.</p>
<p>We gleaned this information from our observations today when Benzinga's options scanner highlighted 8 extraordinary options activities for Block. This level of activity is out of the ordinary.</p>
<p>The general mood among these heavyweight investors is divided, with 62% leaning bullish and 37% bearish. Among these notable options, 3 are puts, totaling $200,280, and 5 are calls, amounting to $199,426.</p>
<h3>What's The Price Target?</h3>
<p>After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $55.0 and $95.0 for Block, spanning the last three months.</p>
<h3>Analyzing Volume &amp; Open Interest</h3>
<p>Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Block's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Block's significant trades, within a strike price range of $55.0 to $95.0, over the past month.</p>
<h3>Block Call and Put Volume: 30-Day Overview</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1726851809_0.png" alt="Options Call Chart" /></p>
<h3>Biggest Options Spotted:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th style="text-align: right;"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>SQ</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/20/24</td>
<td>$6.1</td>
<td>$6.0</td>
<td>$6.1</td>
<td>$67.50</td>
<td>$123.8K</td>
<td>1.2K</td>
<td style="text-align: right;">203</td>
</tr>
<tr>
<td>SQ</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$4.85</td>
<td>$4.8</td>
<td>$4.8</td>
<td>$65.00</td>
<td>$48.4K</td>
<td>2.3K</td>
<td style="text-align: right;">104</td>
</tr>
<tr>
<td>SQ</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$8.0</td>
<td>$7.85</td>
<td>$7.96</td>
<td>$65.00</td>
<td>$47.7K</td>
<td>7.0K</td>
<td style="text-align: right;">62</td>
</tr>
<tr>
<td>SQ</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$5.75</td>
<td>$5.7</td>
<td>$5.75</td>
<td>$85.00</td>
<td>$40.2K</td>
<td>1.4K</td>
<td style="text-align: right;">100</td>
</tr>
<tr>
<td>SQ</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>10/18/24</td>
<td>$1.97</td>
<td>$1.94</td>
<td>$1.97</td>
<td>$70.00</td>
<td>$37.6K</td>
<td>3.7K</td>
<td style="text-align: right;">403</td>
</tr>
</tbody>
</table>
</p>
<h3>About Block</h3>
<p>Founded in 2009, Block provides payment services to merchants, along with related services. The company also launched Cash App, a person-to-person payment network. In 2023, Square's payment volume was a little over $200 million.</p>
<h3>Present Market Standing of Block</h3>
<ul>
<li>With a volume of 3,661,976, the price of SQ is down -1.49% at $67.62. </li>
<li>RSI indicators hint that the underlying stock may be approaching overbought.</li>
<li>Next earnings are expected to be released in 41 days.</li>
</ul>
<h3>What The Experts Say On Block</h3>
<p>A total of 2 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $81.0.</p>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.<br />
&#x2A; Consistent in their evaluation, an analyst from UBS keeps a Buy rating on Block with a target price of $92.<br />
&#x2A; Reflecting concerns, an analyst from New Street Research lowers its rating to Neutral with a new price target of $70.</p>
<p>Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.</p>
<p>If you want to stay updated on the latest options trades for Block, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.</p>


Block Unusual Options Activity

<p>Investors with a lot of money to spend have taken a bearish stance on <strong>Vertiv Hldgs</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VRT#NYSE">VRT</a>).</p>
<p>And retail traders should know.</p>
<p>We noticed this today when the positions showed up on publicly available options history that we track here at Benzinga.</p>
<p>Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with VRT, it often means somebody knows something is about to happen.</p>
<p>Today, Benzinga's options scanner spotted 13 options trades for <strong>Vertiv Hldgs</strong>.</p>
<p>This isn't normal.</p>
<p>The overall sentiment of these big-money traders is split between 23% bullish and 38%, bearish.</p>
<p>Out of all of the options we uncovered, there was 1 put, for a total amount of $57,810, and 12, calls, for a total amount of $1,243,555.</p>
<h3>Predicted Price Range</h3>
<p>Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $75.0 to $130.0 for Vertiv Hldgs over the last 3 months. </p>
<h3>Insights into Volume &amp; Open Interest</h3>
<p>Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Vertiv Hldgs's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Vertiv Hldgs's whale trades within a strike price range from $75.0 to $130.0 in the last 30 days. </p>
<h3>Vertiv Hldgs Option Volume And Open Interest Over Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1726851803_0.png" alt="Options Call Chart" /></p>
<h3>Largest Options Trades Observed:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th style="text-align: right;"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>VRT</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$18.6</td>
<td>$18.4</td>
<td>$18.6</td>
<td>$82.50</td>
<td>$226.9K</td>
<td>437</td>
<td style="text-align: right;">123</td>
</tr>
<tr>
<td>VRT</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/17/25</td>
<td>$5.6</td>
<td>$5.4</td>
<td>$5.5</td>
<td>$115.00</td>
<td>$165.0K</td>
<td>1.6K</td>
<td style="text-align: right;">312</td>
</tr>
<tr>
<td>VRT</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>09/20/24</td>
<td>$8.2</td>
<td>$7.9</td>
<td>$7.9</td>
<td>$85.00</td>
<td>$158.0K</td>
<td>3.1K</td>
<td style="text-align: right;">225</td>
</tr>
<tr>
<td>VRT</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>03/21/25</td>
<td>$5.6</td>
<td>$5.4</td>
<td>$5.5</td>
<td>$130.00</td>
<td>$118.2K</td>
<td>570</td>
<td style="text-align: right;">216</td>
</tr>
<tr>
<td>VRT</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>09/27/24</td>
<td>$2.45</td>
<td>$2.35</td>
<td>$2.43</td>
<td>$94.00</td>
<td>$113.3K</td>
<td>209</td>
<td style="text-align: right;">512</td>
</tr>
</tbody>
</table>
</p>
<h3>About Vertiv Hldgs</h3>
<p>Vertiv Holdings Co brings together hardware, software, analytics and ongoing services to ensure its customers vital applications run continuously, perform optimally and grow with their business needs. The company solves the important challenges faced by data centers, communication networks and commercial and industrial facilities with a portfolio of power, cooling and IT infrastructure solutions and services that extends from the cloud to the edge of the network. Its services include critical power, thermal management, racks and enclosures, monitoring and management, and other services. Its three business segments include the Americas, Asia Pacific; and Europe, Middle East &amp; Africa.</p>
<p>Having examined the options trading patterns of Vertiv Hldgs, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance</p>
<h3>Vertiv Hldgs's Current Market Status</h3>
<ul>
<li>Currently trading with a volume of 3,157,242, the VRT's price is up by 0.71%, now at $92.71. </li>
<li>RSI readings suggest the stock is currently is currently neutral between overbought and oversold.</li>
<li>Anticipated earnings release is in 33 days.</li>
</ul>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.</p>
<p>Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Vertiv Hldgs options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.</p>


Behind the Scenes of Vertiv Hldgs's Latest Options Trends

<p>BTIG  analyst Peter Saleh   maintains Darden Restaurants (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DRI#NYSE">DRI</a>) with a Buy and raises the price target from $175 to $195.</p>


Price Target

Analyst Ratings

BTIG Maintains Buy on Darden Restaurants, Raises Price Target to $195

Federal Reserve

Fed's Bowman Says Such An Approach Would Avoid Unnecessarily Stoking Demand; Economy Remains Strong And Labor Market Remains Near Full Employment; My Reading Of Labor Market Data Has Become More Uncertain Because Of Measurement Challenges, Difficulty Assessing Immigration Impact; Respect And Appreciate That Colleagues Preferred To Go With A Larger Reduction, Remain Committed To Working With Them To Ensure Policy Is Appropriately Positioned To Achieve Dual Mandate Goals

Fed's Bowman On Dissent Says Agreed Was Appropriate At This Meeting To Recalibrate Fed Funds Rate Level But Preferred A Smaller First Move; Sees Risk That The Fomc's Larger Policy Action Could Be Interpreted As A Premature Declaration Of Victory On Inflation; We Have Not Yet Achieved Inflation Goal; Believe Moving At A Measured Pace Toward A More Neutral Policy Stance Will Ensure Further Progress Is Made In Returning Inflation To 2% Goal

<p>Apollo Global Management (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APO#NYSE">APO</a>) has outperformed the market over the past 10 years by 6.87% on an annualized basis producing an average annual return of 18.08%. Currently, Apollo Global Management has a market capitalization of $70.17 billion. </p>
<p><strong>Buying $1000 In APO:</strong> If an investor had bought $1000 of APO stock 10 years ago, it would be worth <strong>$5,251.92</strong> today based on a price of $123.21 for APO at the time of writing.</p>
<h3>Apollo Global Management's Performance Over Last 10 Years</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1726851693_0.png" alt="comp_fig" /></p>
<p>Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.</p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


$1000 Invested In Apollo Global Management 10 Years Ago Would Be Worth This Much Today

<p>Insmed (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INSM#NASDAQ">INSM</a>) has outperformed the market over the past 10 years by 7.39% on an annualized basis producing an average annual return of 18.6%. Currently, Insmed has a market capitalization of $12.71 billion. </p>
<p><strong>Buying $100 In INSM:</strong> If an investor had bought $100 of INSM stock 10 years ago, it would be worth <strong>$561.05</strong> today based on a price of $73.95 for INSM at the time of writing.</p>
<h3>Insmed's Performance Over Last 10 Years</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1726851688_0.png" alt="comp_fig" /></p>
<p>Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.</p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


INSM

Here's How Much You Would Have Made Owning Insmed Stock In The Last 10 Years

<p>In the latest quarter, 5 analysts provided ratings for Capricor Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAPR#NASDAQ">CAPR</a>), showcasing a mix of bullish and bearish perspectives.</p>
<p>The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;"><strong>Bullish</strong></th>
<th style="text-align: right;"><strong>Somewhat Bullish</strong></th>
<th style="text-align: right;"><strong>Indifferent</strong></th>
<th style="text-align: right;"><strong>Somewhat Bearish</strong></th>
<th style="text-align: right;"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
<p>Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $23.0, along with a high estimate of $40.00 and a low estimate of $8.00. Surpassing the previous average price target of $22.80, the current average has increased by 0.88%.</p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1726851677_0.png" alt="price target chart" /></p>
<h2>Diving into Analyst Ratings: An In-Depth Exploration</h2>
<p>The perception of Capricor Therapeutics by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Kristen Kluska</td>
<td>Cantor Fitzgerald</td>
<td>Maintains</td>
<td>Overweight</td>
<td>$8.00</td>
<td>$8.00</td>
</tr>
<tr>
<td>Leland Gershell</td>
<td>Oppenheimer</td>
<td>Raises</td>
<td>Outperform</td>
<td>$15.00</td>
<td>$14.00</td>
</tr>
<tr>
<td>Jason McCarthy</td>
<td>Maxim Group</td>
<td>Maintains</td>
<td>Buy</td>
<td>$12.00</td>
<td>$12.00</td>
</tr>
<tr>
<td>Joseph Pantginis</td>
<td>HC Wainwright &amp; Co.</td>
<td>Maintains</td>
<td>Buy</td>
<td>$40.00</td>
<td>$40.00</td>
</tr>
<tr>
<td>Joseph Pantginis</td>
<td>HC Wainwright &amp; Co.</td>
<td>Maintains</td>
<td>Buy</td>
<td>$40.00</td>
<td>$40.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Capricor Therapeutics. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of Capricor Therapeutics compared to the broader market.</li>
<li><strong>Price Targets:</strong> Gaining insights, analysts provide estimates for the future value of Capricor Therapeutics's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
<p>Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Capricor Therapeutics's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/CAPR/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Capricor Therapeutics analyst ratings.</strong></a></p>
<p>If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.</p>
<h2>Unveiling the Story Behind Capricor Therapeutics</h2>
<p>Capricor Therapeutics Inc is a United States-based biotechnology company focused on the discovery, development, and commercialization of first-in-class biological therapies for the treatment of diseases, with a focus on Duchenne muscular dystrophy and other medical conditions. The company's development stage product pipeline includes CAP-1002, for Duchenne Muscular Dystrophy Program and COVID-19 Program; CDC-Exosomes (CAP-2003); and Exosome-mRNA vaccine.</p>
<h3>Breaking Down Capricor Therapeutics's Financial Performance</h3>
<p><strong>Market Capitalization Analysis:</strong> Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.</p>
<p><strong>Revenue Growth:</strong> Capricor Therapeutics displayed positive results in 3 months. As of 30 June, 2024, the company achieved a solid revenue growth rate of approximately <strong>1.38%</strong>. This indicates a notable increase in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Health Care sector.</p>
<p><strong>Net Margin:</strong> Capricor Therapeutics's net margin is impressive, surpassing industry averages. With a net margin of <strong>-276.97%,</strong> the company demonstrates strong profitability and effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of <strong>-73.49%,</strong> the company may need to address challenges in generating satisfactory returns for shareholders.</p>
<p><strong>Return on Assets (ROA):</strong> Capricor Therapeutics's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of <strong>-25.08%,</strong> the company may face hurdles in achieving optimal financial returns.</p>
<p><strong>Debt Management:</strong> Capricor Therapeutics's debt-to-equity ratio is below the industry average at <strong>0.16</strong>, reflecting a lower dependency on debt financing and a more conservative financial approach.</p>
<h2>What Are Analyst Ratings?</h2>
<p>Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.</p>
<p>Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.</p>
<p>Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.</p>
<p>If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.</p>
<p><strong>Which Stocks Are Analysts Recommending Now?</strong></p>
<p>Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights"><strong>Click here to stay ahead of the market</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


CAPR

Deep Dive Into Capricor Therapeutics Stock: Analyst Perspectives (5 Ratings)

<p>10 analysts have expressed a variety of opinions on Banc of California (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BANC#NYSE">BANC</a>) over the past quarter, offering a diverse set of opinions from bullish to bearish.</p>
<p>The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;"><strong>Bullish</strong></th>
<th style="text-align: right;"><strong>Somewhat Bullish</strong></th>
<th style="text-align: right;"><strong>Indifferent</strong></th>
<th style="text-align: right;"><strong>Somewhat Bearish</strong></th>
<th style="text-align: right;"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">8</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
<p>The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $14.8, a high estimate of $17.00, and a low estimate of $13.00. A 1.33% drop is evident in the current average compared to the previous average price target of $15.00. </p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1726851663_0.png" alt="price target chart" /></p>
<h2>Understanding Analyst Ratings: A Comprehensive Breakdown</h2>
<p>A comprehensive examination of how financial experts perceive Banc of California is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Brandon King</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Hold</td>
<td>$16.00</td>
<td>$15.00</td>
</tr>
<tr>
<td>Michael Rose</td>
<td>Raymond James</td>
<td>Announces</td>
<td>Outperform</td>
<td>$16.00</td>
<td>-</td>
</tr>
<tr>
<td>Andrew Terrell</td>
<td>Stephens &amp; Co.</td>
<td>Maintains</td>
<td>Equal-Weight</td>
<td>$14.00</td>
<td>$14.00</td>
</tr>
<tr>
<td>Andrew Terrell</td>
<td>Stephens &amp; Co.</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$14.00</td>
<td>$15.00</td>
</tr>
<tr>
<td>David Chiaverini</td>
<td>Wedbush</td>
<td>Maintains</td>
<td>Neutral</td>
<td>$14.00</td>
<td>$14.00</td>
</tr>
<tr>
<td>Jared Shaw</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$14.00</td>
<td>$15.00</td>
</tr>
<tr>
<td>Brandon King</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Hold</td>
<td>$15.00</td>
<td>$13.00</td>
</tr>
<tr>
<td>Christopher Mcgratty</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$17.00</td>
<td>$18.00</td>
</tr>
<tr>
<td>Timur Braziler</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$15.00</td>
<td>$16.00</td>
</tr>
<tr>
<td>Brandon King</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Hold</td>
<td>$13.00</td>
<td>$15.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Banc of California. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Banc of California compared to the broader market.</li>
<li><strong>Price Targets:</strong> Gaining insights, analysts provide estimates for the future value of Banc of California's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
<p>Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Banc of California's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/BANC/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Banc of California analyst ratings.</strong></a></p>
<h2>Delving into Banc of California's Background</h2>
<p>Banc of California Inc is a financial holding company. It offers banking and financial services. The company's services include banking services, lending services, and private banking services. Its deposit and banking product and service offerings include checking, savings, money market, certificates of deposit, and retirement accounts. Lending activities are focused on providing financing to California's diverse private businesses, entrepreneurs, and communities, and loans are often secured by California commercial and residential real estate. The company has one reportable segment named Commercial banking.</p>
<h3>Understanding the Numbers: Banc of California's Finances</h3>
<p><strong>Market Capitalization Perspectives:</strong> The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.</p>
<p><strong>Revenue Growth:</strong> Banc of California's revenue growth over a period of 3 months has been noteworthy. As of 30 June, 2024, the company achieved a revenue growth rate of approximately <strong>383.32%</strong>. This indicates a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Financials sector.</p>
<p><strong>Net Margin:</strong> Banc of California's net margin is impressive, surpassing industry averages. With a net margin of <strong>8.0%,</strong> the company demonstrates strong profitability and effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> Banc of California's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of <strong>0.7%,</strong> the company may face hurdles in achieving optimal financial performance.</p>
<p><strong>Return on Assets (ROA):</strong> Banc of California's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of <strong>0.06%,</strong> the company may encounter challenges in delivering satisfactory returns from its assets.</p>
<p><strong>Debt Management:</strong> The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of <strong>0.82</strong>, caution is advised due to increased financial risk.</p>
<h2>Analyst Ratings: Simplified</h2>
<p>Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.</p>
<p>Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.</p>
<p>If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.</p>
<p><strong>Which Stocks Are Analysts Recommending Now?</strong></p>
<p>Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights"><strong>Click here to stay ahead of the market</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


BANC

A Glimpse Into The Expert Outlook On Banc of California Through 10 Analysts

<p>TD Cowen  analyst Brendan Smith   maintains Ginkgo Bioworks Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DNA#NYSE">DNA</a>) with a Buy and raises the price target from $3 to $10.</p>


TD Cowen Maintains Buy on Ginkgo Bioworks Holdings, Raises Price Target to $10

APTV

INDY

CNBC Final Trades: Samsara, Constellation Energy, Aptiv, iShares India 50 ETF

<p>In the latest quarter, 7 analysts provided ratings for Hancock Whitney (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HWC#NASDAQ">HWC</a>), showcasing a mix of bullish and bearish perspectives.</p>
<p>The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;"><strong>Bullish</strong></th>
<th style="text-align: right;"><strong>Somewhat Bullish</strong></th>
<th style="text-align: right;"><strong>Indifferent</strong></th>
<th style="text-align: right;"><strong>Somewhat Bearish</strong></th>
<th style="text-align: right;"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
<p>The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $56.29, a high estimate of $63.00, and a low estimate of $47.00. This upward trend is evident, with the current average reflecting a 8.25% increase from the previous average price target of $52.00.</p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1726851640_0.png" alt="price target chart" /></p>
<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
<p>In examining recent analyst actions, we gain insights into how financial experts perceive Hancock Whitney. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Brandon King</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Hold</td>
<td>$56.00</td>
<td>$57.00</td>
</tr>
<tr>
<td>Gary Tenner</td>
<td>DA Davidson</td>
<td>Raises</td>
<td>Buy</td>
<td>$63.00</td>
<td>$57.00</td>
</tr>
<tr>
<td>Catherine Mealor</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Raises</td>
<td>Outperform</td>
<td>$60.00</td>
<td>$55.00</td>
</tr>
<tr>
<td>Brandon King</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Hold</td>
<td>$57.00</td>
<td>$49.00</td>
</tr>
<tr>
<td>Stephen Scouten</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Overweight</td>
<td>$62.00</td>
<td>$52.00</td>
</tr>
<tr>
<td>Brandon King</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Hold</td>
<td>$49.00</td>
<td>$46.00</td>
</tr>
<tr>
<td>Casey Haire</td>
<td>Jefferies</td>
<td>Lowers</td>
<td>Hold</td>
<td>$47.00</td>
<td>$48.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Hancock Whitney. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Hancock Whitney compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
<p>Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Hancock Whitney's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/HWC/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Hancock Whitney analyst ratings.</strong></a></p>
<h2>About Hancock Whitney</h2>
<p>Hancock Whitney Corp operates bank offices and financial centers. The company offers a range of traditional and online banking services to commercial, small business and retail customers, providing a variety of transaction and savings deposit products, treasury management services, secured and unsecured loan products (including revolving credit facilities), letters of credit and similar financial guarantees. The Bank provides trust and investment management services to retirement plans, corporations and individuals and provides its customers access to investment advisory and brokerage products.</p>
<h3>A Deep Dive into Hancock Whitney's Financials</h3>
<p><strong>Market Capitalization Analysis:</strong> The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.</p>
<p><strong>Revenue Growth:</strong> Hancock Whitney displayed positive results in 3 months. As of 30 June, 2024, the company achieved a solid revenue growth rate of approximately <strong>0.57%</strong>. This indicates a notable increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Financials sector.</p>
<p><strong>Net Margin:</strong> Hancock Whitney's net margin is impressive, surpassing industry averages. With a net margin of <strong>31.72%,</strong> the company demonstrates strong profitability and effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> Hancock Whitney's ROE excels beyond industry benchmarks, reaching <strong>2.93%</strong>. This signifies robust financial management and efficient use of shareholder equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> Hancock Whitney's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>0.32%</strong> ROA, the company effectively utilizes its assets for optimal returns.</p>
<p><strong>Debt Management:</strong> Hancock Whitney's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of <strong>0.29</strong>.</p>
<h2>How Are Analyst Ratings Determined?</h2>
<p>Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.</p>
<p>Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.</p>
<p><strong>Which Stocks Are Analysts Recommending Now?</strong></p>
<p>Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights"><strong>Click here to stay ahead of the market</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


The Analyst Landscape: 7 Takes On Hancock Whitney

<p>Cullen/Frost Bankers (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CFR#NYSE">CFR</a>) has been analyzed by 12 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.</p>
<p>The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;"><strong>Bullish</strong></th>
<th style="text-align: right;"><strong>Somewhat Bullish</strong></th>
<th style="text-align: right;"><strong>Indifferent</strong></th>
<th style="text-align: right;"><strong>Somewhat Bearish</strong></th>
<th style="text-align: right;"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">8</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
<p>The 12-month price targets, analyzed by analysts, offer insights with an average target of $119.83, a high estimate of $134.00, and a low estimate of $100.00. Witnessing a positive shift, the current average has risen by 2.2% from the previous average price target of $117.25.</p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1726851630_0.png" alt="price target chart" /></p>
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
<p>The standing of Cullen/Frost Bankers among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Brandon King</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Hold</td>
<td>$123.00</td>
<td>$126.00</td>
</tr>
<tr>
<td>Manan Gosalia</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Underweight</td>
<td>$121.00</td>
<td>$112.00</td>
</tr>
<tr>
<td>Brandon King</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Hold</td>
<td>$126.00</td>
<td>$102.00</td>
</tr>
<tr>
<td>Matt Olney</td>
<td>Stephens &amp; Co.</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$131.00</td>
<td>$116.00</td>
</tr>
<tr>
<td>David Chiaverini</td>
<td>Wedbush</td>
<td>Raises</td>
<td>Neutral</td>
<td>$124.00</td>
<td>$106.00</td>
</tr>
<tr>
<td>Peter Winter</td>
<td>DA Davidson</td>
<td>Raises</td>
<td>Buy</td>
<td>$134.00</td>
<td>$127.00</td>
</tr>
<tr>
<td>Jon Arfstrom</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Sector Perform</td>
<td>$120.00</td>
<td>$119.00</td>
</tr>
<tr>
<td>Jon Arfstrom</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Sector Perform</td>
<td>$119.00</td>
<td>$118.00</td>
</tr>
<tr>
<td>Brandon King</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Hold</td>
<td>$102.00</td>
<td>$115.00</td>
</tr>
<tr>
<td>Casey Haire</td>
<td>Jefferies</td>
<td>Lowers</td>
<td>Hold</td>
<td>$108.00</td>
<td>$117.00</td>
</tr>
<tr>
<td>Steven Alexopoulos</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$130.00</td>
<td>$140.00</td>
</tr>
<tr>
<td>John Pancari</td>
<td>Evercore ISI Group</td>
<td>Lowers</td>
<td>Underperform</td>
<td>$100.00</td>
<td>$109.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Cullen/Frost Bankers. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of Cullen/Frost Bankers compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
<p>Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Cullen/Frost Bankers's market standing. Stay informed and make well-considered decisions with our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/CFR/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Cullen/Frost Bankers analyst ratings.</strong></a></p>
<h2>All You Need to Know About Cullen/Frost Bankers</h2>
<p>Cullen/Frost Bankers is a financial holding company, The company offer commercial and consumer banking services, as well as trust and investment management, insurance, brokerage, mutual funds, leasing, treasury management, capital markets advisory and item processing services across Texas in the Austin, Corpus Christi, Dallas, Fort Worth, Houston, Permian Basin, Rio Grande Valley, and San Antonio regions.</p>
<h3>Unraveling the Financial Story of Cullen/Frost Bankers</h3>
<p><strong>Market Capitalization Perspectives:</strong> The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.</p>
<p><strong>Revenue Growth:</strong> Cullen/Frost Bankers displayed positive results in 3 months. As of 30 June, 2024, the company achieved a solid revenue growth rate of approximately <strong>3.91%</strong>. This indicates a notable increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Financials sector.</p>
<p><strong>Net Margin:</strong> Cullen/Frost Bankers's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>27.99%</strong> net margin, the company effectively manages costs and achieves strong profitability.</p>
<p><strong>Return on Equity (ROE):</strong> Cullen/Frost Bankers's ROE excels beyond industry benchmarks, reaching <strong>4.05%</strong>. This signifies robust financial management and efficient use of shareholder equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> Cullen/Frost Bankers's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of <strong>0.29%,</strong> the company showcases efficient use of assets and strong financial health.</p>
<p><strong>Debt Management:</strong> With a below-average debt-to-equity ratio of <strong>0.06</strong>, Cullen/Frost Bankers adopts a prudent financial strategy, indicating a balanced approach to debt management.</p>
<h2>Analyst Ratings: What Are They?</h2>
<p>Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. </p>
<p>Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.</p>
<p><strong>Breaking: Wall Street's Next Big Mover</strong></p>
<p>Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights"><strong>Click here for urgent details</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


What 12 Analyst Ratings Have To Say About Cullen/Frost Bankers

<p>6 analysts have shared their evaluations of Ralph Lauren (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RL#NYSE">RL</a>) during the recent three months, expressing a mix of bullish and bearish perspectives.</p>
<p>In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.</p>
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;"><strong>Bullish</strong></th>
<th style="text-align: right;"><strong>Somewhat Bullish</strong></th>
<th style="text-align: right;"><strong>Indifferent</strong></th>
<th style="text-align: right;"><strong>Somewhat Bearish</strong></th>
<th style="text-align: right;"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
<p>The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $197.67, a high estimate of $207.00, and a low estimate of $193.00. This upward trend is apparent, with the current average reflecting a 0.68% increase from the previous average price target of $196.33.</p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1726851621_0.png" alt="price target chart" /></p>
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
<p>The perception of Ralph Lauren by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Dana Telsey</td>
<td>Telsey Advisory Group</td>
<td>Raises</td>
<td>Outperform</td>
<td>$207.00</td>
<td>$195.00</td>
</tr>
<tr>
<td>Adrienne Yih</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$200.00</td>
<td>$195.00</td>
</tr>
<tr>
<td>John Kernan</td>
<td>TD Cowen</td>
<td>Lowers</td>
<td>Buy</td>
<td>$193.00</td>
<td>$196.00</td>
</tr>
<tr>
<td>Dana Telsey</td>
<td>Telsey Advisory Group</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$195.00</td>
<td>$195.00</td>
</tr>
<tr>
<td>Dana Telsey</td>
<td>Telsey Advisory Group</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$195.00</td>
<td>$195.00</td>
</tr>
<tr>
<td>John Kernan</td>
<td>TD Cowen</td>
<td>Lowers</td>
<td>Buy</td>
<td>$196.00</td>
<td>$202.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Ralph Lauren. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Ralph Lauren compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts predict movements in price targets, offering estimates for Ralph Lauren's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
<p>To gain a panoramic view of Ralph Lauren's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/RL/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Ralph Lauren analyst ratings.</strong></a></p>
<h2>Discovering Ralph Lauren: A Closer Look</h2>
<p>Founded by designer Ralph Lauren in 1967 in New York City, Ralph Lauren Corp. designs, markets, and distributes lifestyle merchandise in North America, Europe, and Asia. Best known for its iconic polo shirts, its products also include other types of apparel, footwear, eyewear, jewelry, handbags, home goods, and fragrances. The company's brands include Ralph Lauren Collection, Polo Ralph Lauren, and Lauren Ralph Lauren. Distribution channels for Ralph Lauren include wholesale (department stores and specialty stores), retail (company-owned retail stores and e-commerce), and licensing.</p>
<h3>Key Indicators: Ralph Lauren's Financial Health</h3>
<p><strong>Market Capitalization Analysis:</strong> With an elevated market capitalization, the company stands out above industry averages, showcasing substantial size and market acknowledgment.</p>
<p><strong>Revenue Growth:</strong> Ralph Lauren displayed positive results in 3 months. As of 30 June, 2024, the company achieved a solid revenue growth rate of approximately <strong>1.05%</strong>. This indicates a notable increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Consumer Discretionary sector.</p>
<p><strong>Net Margin:</strong> Ralph Lauren's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of <strong>11.15%,</strong> the company showcases strong profitability and effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> Ralph Lauren's ROE stands out, surpassing industry averages. With an impressive ROE of <strong>7.0%</strong>, the company demonstrates effective use of equity capital and strong financial performance.</p>
<p><strong>Return on Assets (ROA):</strong> The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of <strong>2.55%,</strong> the company showcases effective utilization of assets.</p>
<p><strong>Debt Management:</strong> The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at <strong>1.13</strong>.</p>
<h2>How Are Analyst Ratings Determined?</h2>
<p>Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.</p>
<p>Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.</p>
<p>Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.</p>
<p><strong>Breaking: Wall Street's Next Big Mover</strong></p>
<p>Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights"><strong>Click here for urgent details</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


The Latest Analyst Ratings For Ralph Lauren

<p>Telsey Advisory Group  analyst Cristina Fernandez   maintains Nike (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NKE#NYSE">NKE</a>) with a Outperform and maintains $100 price target.</p>


Telsey Advisory Group Maintains Outperform on Nike, Maintains $100 Price Target

<p>In the preceding three months, 8 analysts have released ratings for PBF Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PBF#NYSE">PBF</a>), presenting a wide array of perspectives from bullish to bearish.</p>
<p>In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.</p>
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;"><strong>Bullish</strong></th>
<th style="text-align: right;"><strong>Somewhat Bullish</strong></th>
<th style="text-align: right;"><strong>Indifferent</strong></th>
<th style="text-align: right;"><strong>Somewhat Bearish</strong></th>
<th style="text-align: right;"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">5</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
<p>Insights from analysts' 12-month price targets are revealed, presenting an average target of $43.5, a high estimate of $53.00, and a low estimate of $25.00. Observing a downward trend, the current average is 17.74% lower than the prior average price target of $52.88. </p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1726851613_0.png" alt="price target chart" /></p>
<h2>Understanding Analyst Ratings: A Comprehensive Breakdown</h2>
<p>The analysis of recent analyst actions sheds light on the perception of PBF Energy by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Ryan Todd</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Underweight</td>
<td>$25.00</td>
<td>$47.00</td>
</tr>
<tr>
<td>Connor Lynagh</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$38.00</td>
<td>$48.00</td>
</tr>
<tr>
<td>Nitin Kumar</td>
<td>Mizuho</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$42.00</td>
<td>$48.00</td>
</tr>
<tr>
<td>Roger Read</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$51.00</td>
<td>$52.00</td>
</tr>
<tr>
<td>Manav Gupta</td>
<td>UBS</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$44.00</td>
<td>$57.00</td>
</tr>
<tr>
<td>Paul Cheng</td>
<td>Scotiabank</td>
<td>Lowers</td>
<td>Sector Perform</td>
<td>$45.00</td>
<td>$56.00</td>
</tr>
<tr>
<td>John Royall</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$53.00</td>
<td>$58.00</td>
</tr>
<tr>
<td>Neil Mehta</td>
<td>Goldman Sachs</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$50.00</td>
<td>$57.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to PBF Energy. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of PBF Energy compared to the broader market.</li>
<li><strong>Price Targets:</strong> Delving into movements, analysts provide estimates for the future value of PBF Energy's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
<p>Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of PBF Energy's market standing. Stay informed and make data-driven decisions with our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/PBF/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on PBF Energy analyst ratings.</strong></a></p>
<h2>Delving into PBF Energy's Background</h2>
<p>PBF Energy Inc is an independent petroleum refiner and supplier of unbranded transportation fuels, heating oil, petrochemical feedstocks, lubricants, and other petroleum products in the United States. The company owns refineries in Delaware, Ohio, New Jersey, California, and Louisiana. The Company operates in two reportable business segments: Refining and Logistics. The Company's oil refineries are all engaged in the refining of crude oil and other feedstocks into petroleum products and are aggregated into the Refining segment. PBFX operates logistics assets such as crude oil and refined products terminals, pipelines and storage facilities. The Logistics segment consists solely of PBFX's operations.</p>
<h3>Breaking Down PBF Energy's Financial Performance</h3>
<p><strong>Market Capitalization:</strong> Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.</p>
<p><strong>Revenue Growth:</strong> PBF Energy's revenue growth over a period of 3 months has faced challenges. As of 30 June, 2024, the company experienced a revenue decline of approximately <strong>-4.6%</strong>. This indicates a decrease in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Energy sector.</p>
<p><strong>Net Margin:</strong> PBF Energy's net margin is impressive, surpassing industry averages. With a net margin of <strong>-0.75%,</strong> the company demonstrates strong profitability and effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> PBF Energy's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of <strong>-1.03%,</strong> the company may face hurdles in achieving optimal financial performance.</p>
<p><strong>Return on Assets (ROA):</strong> PBF Energy's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of <strong>-0.47%,</strong> the company may face hurdles in achieving optimal financial performance.</p>
<p><strong>Debt Management:</strong> With a below-average debt-to-equity ratio of <strong>0.33</strong>, PBF Energy adopts a prudent financial strategy, indicating a balanced approach to debt management.</p>
<h2>Analyst Ratings: Simplified</h2>
<p>Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.</p>
<p>In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.</p>
<p><strong>Which Stocks Are Analysts Recommending Now?</strong></p>
<p>Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights"><strong>Click here to stay ahead of the market</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Key Takeaways From PBF Energy Analyst Ratings

<p><a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a></p>
<p>Death cross stocks &ndash; on the surface, the title sounds incredibly menacing. However, it may be one of the more misunderstood concepts. By the end of this short introduction, you&rsquo;ll view this indicator in a more nuanced manner.</p>



<p>Simply put, the death cross signal flashes when a shorter-term moving average (typically the 50-day moving average) slips below the longer-term average (usually the 200 DMA). What it indicates is that more recent price action has been volatile compared to the longer-running dynamic. Some might reasonably assume that this is a signal to avoid the impacted equities. However, they could also be contrarian stocks.</p>



<p>Established publicly traded enterprises tend to follow an ebb and flow; that is, they cycle through periods of undervaluation and overvaluation. The death cross is really saying that the pricing is below historical averages (relatively undervalued). So long as the fundamentals are robust, these death cross stocks should be contrarian upside opportunities.</p>



<h2>CoreCivic (CXW)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2024/06/cxw-stock1600-300x169.png" alt="Sign for privately owned Core Civic Detention Center in Otay Mesa, where San Diego County's illegal immigrants are held as they go through the legal process."><div>Source: Simone Hogan / Shutterstock.com</div></div><p>I&rsquo;m going to be upfront: I didn&rsquo;t like private-prison operator <strong>CoreCivic</strong> (NYSE:<a href="https://investorplace.com/stock-quotes/cxw-stock-quote/"><strong>CXW</strong></a>) following the disastrous Republican response to this year&rsquo;s State of the Union address. President Joe Biden &ndash; while flubbing a few lines &ndash; seemed, well, presidential. That aura quickly faded though, when, Biden suffered what may be a catastrophic first debate. To reference the memes, it certainly seems like it&rsquo;s &ldquo;Joe-ver.&rdquo;</p>



<p>The market didn&rsquo;t respond well to CXW stock last month, sending it into the weeds. Following the debate, sentiment started to pick up significantly. However, in the technical charts, CoreCivic is about to incur the &ldquo;dreaded&rdquo; death cross. Fundamentally, I would view this as a contrarian indicator. Again, sentiment has picked up.</p>



<p>In addition, the Republicans have an easy road to the White House. One of former President Donald Trump&rsquo;s key agendas is immigration: no more undocumented workers. The harsh crackdown that is about to happen may bode well for CoreCivic&rsquo;s business. It&rsquo;s an ugly thing to say, I get it. However, it&rsquo;s the reality. Thus, CXW ranks among the death cross stocks to consider.</p>



<h2>Medtronic (MDT)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/08/mdt-stock-1-300x169.jpg" alt="Medtronic (MDT) sign outside office building representing healthcare stocks"><div>Source: JHVEPhoto / Shutterstock.com</div></div><p>One of the top medical device firms, <strong>Medtronic</strong> (NYSE:<a href="https://investorplace.com/stock-quotes/mdt-stock-quote/"><strong>MDT</strong></a>) specializes in a wide range of advanced solutions, from implantable cardiac pacemakers to insulin pumps for the purposes of diabetes management. While relevant, that alone won&rsquo;t guarantee anything on the Street. MDT finds itself down about 6% year-to-date and 10% down in the past 52 weeks. Technically, it&rsquo;s one of the death cross stocks.</p>



<p>However, speculators may want to give Medtronic a second look. In terms of the financials, it&rsquo;s doing alright. In the past four quarters, the company posted an average earnings per share of $1.30. During the period, analysts anticipated an average EPS of $1.25. The performance yielded an earnings surprise of 4.48%.</p>



<p>Attractively, MDT stock now trades at 3.21X trailing-year sales. Between the first quarters of 2023 and 2024, this metric stood at 3.53X. Also, MDT trades at 14.37X forward earnings. In contrast, the prior year&rsquo;s average stood at 15.82X.</p>



<p>Experts see modest growth in both earnings and sales for the current fiscal year and the next. Thus, MDT is one of the contrarian stocks to consider.</p>



<h2>Block (SQ)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/06/sq-1600-300x169.jpg" alt="Block logo over a background with former square logo. SQ stock."><div>Source: Sergei Elagin / Shutterstock</div></div><p>Financial technology (fintech) giant <strong>Block</strong> (NYSE:<a href="https://investorplace.com/stock-quotes/sq-stock-quote/"><strong>SQ</strong></a>) needs no introduction. Formerly known as Square, Block primarily serves small businesses with its payment processing equipment and systems. This facilitation enabled small companies to compete more effectively with their larger peers. However, pressures against the consumer economy have negatively impacted SQ. So, it&rsquo;s just on the verge of becoming one of the death cross stocks.</p>



<p>However, SQ stock has rocketed higher in recent sessions. So, it might be possible for Block to escape the label. Either way, Block seems like an opportunity since it&rsquo;s still trading at a heavy discount relative to levels seen in 2021. With another Trump administration possibly imminent, this raises questions about broader business viability. Still, conservative leadership could be good for cryptocurrencies, one of Block&rsquo;s product offerings.</p>



<p>Also, consider that the market prices Block at only 21.69X forward earnings. In the prior year, Wall Street accepted a valuation of 30.47X. So, SQ has room to grow. That&rsquo;s enticing because analysts see expansion of the bottom line to $3.48 EPS, a near doubling from last year. Also, sales could see a 15% boost to $25.21 billion. So, we could be looking at one of the contrarian stocks.</p>



<h2>Hormel (HRL)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/04/hrl-1600-300x169.png" alt="Hormel Foods Logo shown on a laptop screen behind a phone screen also showing the logo. HRL stock."><div>Source: viewimage / Shutterstock</div></div><p>Let&rsquo;s get into some of the riskier (but potentially more rewarding) ideas among death cross stocks, starting with <strong>Hormel</strong> (NYSE:<a href="https://investorplace.com/stock-quotes/hrl-stock-quote/"><strong>HRL</strong></a>). As a food processing company, you&rsquo;d expect Hormel to perform well. During periods of inflation and high borrowing costs, consumers may look to save money. That means more of the consumer budget may go toward the grocery aisle (as opposed to fancy restaurants).</p>



<p>Unfortunately, that narrative hasn&rsquo;t exactly panned out well for HRL stock. Since the beginning of January, HRL is down more than 4%. In the past 52 weeks, it&rsquo;s off the pace by over 20%. Even in the past five years, HRL has gone nowhere except down, losing 24%. Still, it&rsquo;s possible that the bulls may have drawn a line in the sand back in February.</p>



<p>Technically, that may have been the bottom. Whatever the case, the market prices HRL stock at only 1.43X trailing-year sales. In the prior year, this metric landed at 1.62X. Also, its forward price-earnings (PE) ratio is 18.45X, lower than the prior year&rsquo;s average of 21.39X.</p>



<p>Over the next two years, analysts call for slow but steady expansion in the top and bottom lines. Thus, keep it on your radar of contrarian stocks.</p>



<h2>Iovance Biotherapeutics (IOVA)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/06/biotechnologyepzm1600-300x169.png" alt="OLK Stock. Modern Medical Research Laboratory: Two Scientists Wearing Face Masks use Microscope, Analyse Sample in Petri Dish, Talk. Advanced Scientific Lab for Medicine, Biotechnology. Blue Color. KZR stock. RSLS stock. Best Biotech Stocks to Buy"><div>Source: Gorodenkoff / Shutterstock.com</div></div><p>A commercial-stage biotechnology firm, <strong>Iovance Biotherapeutics</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/iova-stock-quote/"><strong>IOVA</strong></a>) develops and commercializes cell therapies for the treatment of metastatic melanoma and other solid tumor cancers. On the surface, Iovance appears incredibly relevant. As stated earlier, though, relevance alone offers no guarantees of market success. Due to losses extending back to early 2021, IOVA is about to become one of the death cross stocks.</p>



<p>That might not be as bad as it may sound to those unfamiliar with the indicator&rsquo;s nuances. For one thing, IOVA stock has enjoyed some strong sessions recently. Also, as <em>InvestorPlace</em> contributor Joel Lim mentioned, Iovance <a href="https://investorplace.com/2024/07/3-under-10-biotech-stocks-that-could-make-you-rich/">features two drugs in the market</a> and additional compelling therapeutic candidates in clinical trials. I wouldn&rsquo;t sleep on this idea.</p>



<p>Another consideration is analysts&rsquo; expectations. For fiscal 2024, they&rsquo;re targeting a loss per share of $1.38, which is a significant improvement from last year&rsquo;s $1.89 in the red. In the following year, Iovance could whittle the loss down to 73 cents per share.</p>



<p>However, the big catalyst could be revenue of $153.92 million in 2024, which is a gargantuan leap from last year&rsquo;s $1.19 million. So, keep IOVA on your list of contrarian stocks.</p>



<h2>Kura Sushi USA (KRUS)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2020/02/sushi1600-300x169.jpg" alt="Two rolls of sushi on a platter."><div>Source: Shutterstock</div></div><p>Niche restaurant <strong>Kura Sushi USA</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/krus-stock-quote/"><strong>KRUS</strong></a>) is an enticing idea if you like to speculate. First, Americans really love their sushi but there&rsquo;s a problem. It takes time to prepare &ndash; well, at least the good ones do. So, waiting for your sushi and other entrees is a hassle. Enter Kura. Basically, your sushi and other food items are rolling along a conveyer belt. You pick what you want.</p>



<p>Of course, you can special order certain items and these can be whisked directly to your table. The beauty of Kura&rsquo;s business model is that people can start eating right away while they wait for their favorites. That might actually save time for the restaurant operators: people get fuller quickly and leave the table. And that opens up a table for the next guest(s).</p>



<p>However, Wall Street hates KRUS stock, sending it down more than 21%. Maybe prospective investors are getting KRUS mixed up with <strong>Kura Oncology</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/kura-stock-quote/"><strong>KURA</strong></a>). Stranger things have happened. Whatever the case, Kura the restaurant trades for 2.61X sales. In the prior year, this metric clocked in at 4.7X.</p>



<p>Analysts are looking for fiscal 2024 sales to hit $236.89 million. That&rsquo;s up 26.4%, making KRUS one of the contrarian stocks to consider.</p>



<h2>TAL Education (TAL)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2020/08/online-education-1600-300x169.jpg" alt="a child takes notes while attending an online class. represents education stocks. edtech stocks"><div>Source: Travelerpix / Shutterstock.com</div></div><p>You&rsquo;ve come this far for compelling death cross stocks so let&rsquo;s end on a good one with <strong>TAL Education</strong> (NYSE:<a href="https://investorplace.com/stock-quotes/tal-stock-quote/"><strong>TAL</strong></a>). Falling under the education and training services industry, TAL is incredibly relevant. It offers K-12 afterschool tutoring services, leveraging the latest technologies and tools, such as artificial intelligence and mobile apps. However, it&rsquo;s based in China and that&rsquo;s where things get squirrely.</p>



<p>Because many questions hang over the health of the Chinese economy &ndash; particularly with its consumer ecosystem &ndash; the concept of an afterschool tutoring service may seem superfluous; that is, households may be tempted to axe it from the budget. TAL stock is down more than 15% YTD, providing some weight to the concerns.</p>



<p>Fundamentally, though, the <a href="http://aare.edu.au/data/publications/2006/wan06122.pdf">Chinese culture values education</a>. Further, China is locked in a geopolitical competition with the U.S. and major western powers. Education is the way for the next generation to get ahead and that ultimately makes TAL stock a viable investment.</p>



<p>Analysts agree and this is why I&rsquo;m excited about the idea: they view TAL as a <a href="https://www.tipranks.com/stocks/tal/forecast">unanimous strong buy</a>. Also, their average price target of $17.78 implies almost 78% upside potential. It doesn&rsquo;t get much better than that.</p>



<p><em>On the date of publication, Josh Enomoto</em><em> did not have (either directly or indirectly) any positions in the securities mentioned in this article.&nbsp;</em><em>The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com&nbsp;</em><a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank"><em>Publishing Guidelines</em></a><em>.</em><em></em></p>
<div><p>A former senior business analyst for Sony Electronics, Josh Enomoto has helped broker major contracts with Fortune Global 500 companies. Over the past several years, he has delivered unique, critical insights for the investment markets, as well as various other industries including legal, construction management, and healthcare. Tweet him at @EnomotoMedia.</p></div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	
<p>The post <a href="https://investorplace.com/2024/07/7-death-cross-stocks-that-could-be-contrarian-buys/">7 &#8216;Death Cross&#8217; Stocks That Could Be Contrarian Buys</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.</p>

7 'Death Cross' Stocks That Could Be Contrarian Buys

Voya Small Cap Growth Strategy Q2 2024 Commentary

Barclays creates growth-quality basket for targeted approach to small-cap stocks

<p><a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a></p>
<p>The first lesson in investing is that returns are not guaranteed &mdash; especially in stocks. Companies constantly fluctuate in value as the wheel of the stock market turns, and daily trades come in by the millions. With so much chaos, predicting if a stock will increase by 3 or even 10 times might seem closer to crystal ball work than actual informed analysis. However, some stocks <em>do </em>display high growth potential, which could lead to significant gains in the future.</p>



<p>In this article, I&rsquo;ll examine three stocks I believe have the potential to grow tenfold in the coming years. To get my list, I screened the market using the criteria below:</p>



<ul><li>Small-cap stocks (between $300 million and $2 billion)</li>



<li>Consecutive positive growth in earnings and revenue in the last three fiscal years</li>



<li>Minimum of eight analysts&rsquo; coverage</li>



<li>Minimum Buy rating from analysts</li>
</ul><p>Selecting stocks with these criteria allows me to focus on companies showing consistent growth. Furthermore, the analyst ratings show they have a strong following on Wall Street.&nbsp;</p>



<p>Then, I arranged the companies based on the lowest to highest market cap. Here are the results.</p>



<h2>Kura Sushi USA (KRUS)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2020/02/sushi1600-300x169.jpg" alt="Two rolls of sushi on a platter."><div>Source: Shutterstock</div></div><p>If you like sushi, you&rsquo;d love a revolving one. <strong>Kura Sushi USA </strong>(NASDAQ:<span><a href="https://investorplace.com/stock-quotes/krus-stock-quote/"><strong>KRUS</strong></a></span>) is a Japanese restaurant chain specializing in conveyor belt sushi. The company operates in 15 states, including Washington and the District of Columbia, with a market cap of <a href="https://www.nasdaq.com/market-activity/stocks/krus">almost $600 million.</a>&nbsp;Kura Sushi serves a comprehensive <span>menu that includes nigiri, rolls, noodles and desserts.</span></p>



<p>The company ended Q3&rsquo;24 on a strong footing. Sales broke <a href="https://ir.kurausa.com/news-releases/news-release-details/kura-sushi-usa-announces-fiscal-third-quarter-2024-financial">$63 million</a> compared to $49.2 million in the same quarter last year. While Kura Sushi experienced a net loss of $0.6 million, restaurant-level operating profit was $12.6 million, accounting for 20% of sales.&nbsp;</p>



<p>Kura Sushi&rsquo;s commitment to growth is evident. For example, the restaurant chain<span> recently appointed&nbsp;<a href="https://ir.kurausa.com/news-releases/news-release-details/kura-sushi-usa-announces-appointment-treasa-bowers-companys" target="_blank">Treasa Bowers</a>&nbsp;to its</span> board of directors. It also opened 4 new restaurants during the quarter, with plans for 14 new openings in the fiscal year. This expansion has fueled the company&rsquo;s growth, leading to exponential revenue and net income increases over the <a href="https://finance.yahoo.com/quote/KRUS/financials/">last three fiscal years.</a></p>



<p>The expansion seems to be working, as 2023 marked a turnaround from an 8-cent loss to a 15-cent profit per share.&nbsp;</p>



<p>Combine this with Wall Street&rsquo;s <a href="https://www.nasdaq.com/market-activity/stocks/krus/analyst-research">Buy rating,</a> and we may be looking at one of the most promising high-growth potential stocks in KRUS.</p>



<h2>ProPetro Holding (PUMP)</h2>



<p><strong>ProPetro Holding </strong>(NYSE:<span><a href="https://investorplace.com/stock-quotes/pump-stock-quote/"><strong>PUMP</strong></a></span>), a leader in oilfield services in the Permian Basin, focuses on wireline, hydraulic fracturing and other complementary services for upstream oil and gas companies. The company<span>, with a market cap north of&nbsp;<a href="https://www.nasdaq.com/market-activity/stocks/pump" target="_blank">$945 million,</a>&nbsp;</span>conducts cementing operations and provides wet sand solutions for its customers in the oil and natural gas industry. <a href="https://ir.propetroservices.com/news-events/press-releases/detail/119/propetro-acquires-aqua-prop-an-innovative-wet-sand-solutions-provider">ProPetro recently acquired Aqua Prop</a> to complement its core business with cost-effective wet sand solutions.</p>



<p>Last year was ProPetro&rsquo;s year. The company reported a 27% year-over-year (YOY) increase in revenue, the fruit of a two-year, $1 billion-dollar investment in new technologies.</p>



<p>Additionally, net income jumped from $2 million to $86 million, a nearly <em>4,200% increase.</em> ProPetro&rsquo;s 2023 performance shows great promise, especially considering its <a href="https://finance.yahoo.com/quote/PUMP/financials/">continuous revenue and income growth</a> over the last three years.</p>




<p><a href="https://ir.propetroservices.com/news-events/press-releases/detail/113/propetro-reports-financial-results-for-the-fourth-quarter-and-full-year-of-2023">CFO David Schorlemer said,</a> &ldquo;These investments in dual-fuel conversions, electric frac technology, and the tremendous progress in our optimization program will lead to a sizeable decrease in capital spending and an improved operating expense profile going forward.&rdquo;&nbsp;</p>




<p>Analysts have noticed PetroPro as one of the most attractive high-growth potential stocks, rating PUMP stock as a <a href="https://www.nasdaq.com/market-activity/stocks/pump/analyst-research">solid Buy.</a>&nbsp;</p>



<h2>Endava (DAVA)</h2>



<p>A champion in driving meaningful change, <strong>Endava </strong>(NYSE:<span><a href="https://investorplace.com/stock-quotes/dava-stock-quote/"><strong>DAVA</strong></a></span>) is a software company that specializes in software development, consulting and automation solutions. The company uses its TEAM Enterprise Agile Scaling (TEAS) framework to develop and test actionable insights as a scalable solution.&nbsp;</p>



<p>Even with a market cap of around <a href="https://www.nasdaq.com/market-activity/stocks/dava">$1.8 billion</a> &mdash; smaller than most tech giants &mdash; the company has built a strong brand that spans across the globe. This is evident in the expansion of its partnership with <a href="https://investors.endava.com/news-events/press-releases/detail/89/endava-continues-technical-excellence-in-apac-region-with-expansion-of-partnership-with-google-cloud">Google Cloud</a> for expanding support in the APAC region.&nbsp;</p>



<p>Endava reported solid growth in 2023. Revenue reached &pound;794.7 million (roughly $1.02 billion), <a href="https://investors.endava.com/news-events/press-releases/detail/77/endava-announces-fourth-quarter-fiscal-year-2023-fiscal-year-2023-results">growing 21.4% YOY,</a> while net income reached &pound;94.2 million ($121.05 million) against the previous year&rsquo;s &pound;83.1 million ($106.78 million).</p>



<p>This growth aligns with its <a href="https://finance.yahoo.com/quote/DAVA/financials/">overall upward trajectory</a> over the past three years.&nbsp;While the company is <a href="https://investors.endava.com/news-events/press-releases/detail/88/endava-announces-third-quarter-fiscal-year-2024-results">experiencing a challenging 2024,</a> 11 analysts maintain their <a href="https://www.nasdaq.com/market-activity/stocks/dava/analyst-research">Strong Buy</a> rating for DAVA stock.</p>



<p><em>On the date of publication, Rick Orford did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com </em><a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/"><em>Publishing Guidelines.</em></a></p>



<p><em>On the date of publication, the responsible editor did not have (either directly or indirectly) any positions in the securities mentioned in this article.</em></p>
<div><p>Rick Orford is a Wall Street Journal best-selling author, investor, influencer, and mentor. His work has appeared in the most authoritative publications, including Good Morning America, Washington Post, Yahoo Finance, MSN, Business Insider, NBC, FOX, CBS, and ABC News.</p></div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>
<p>The post <a href="https://investorplace.com/2024/07/dont-miss-out-3-stocks-poised-for-a-10x-surge/">Don&#8217;t Miss Out: 3 Stocks Poised for a 10X Surge</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.</p>

Don't Miss Out: 3 Stocks Poised for a 10X Surge

Starbucks holds its post-earnings gain as investors eye improving North American trends

Kura Sushi: They Have The Growth, But They Don't Have The Profitability

Catalyst Watch: August Jobs Report, Intel event, Broadcom earnings, and Costco sales

Wall Street Breakfast: The Week Ahead

First Watch Restaurant: A Non-Traditional Recipe For Dealing With Traffic

State of the consumer: Airbnb, Wayfair, and Stitch Fix leads gains in the retail sector

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Comments

Kura Sushi USA

Kura Sushi USA (KRUS) Forecast

Kura Sushi USA (NASDAQ:KRUS) Stock, Quote.Headers.trade-ideas